Speech-Language Pathologists in Greensburg, KY Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Mrs. Lisa Karen Simpson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Policeman Way, Greensburg, KY 42743 Phone: 270-789-9537    Fax: 270-932-9811

Shelia Mckinley Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 202 - 206 Milby Street, Greensburg, KY 42743 Phone: 270-932-4211    Fax: 270-932-3504

Mrs. Carrie Renee Kessler, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Kessler Ln, Greensburg, KY 42743 Phone: 270-299-1059    Fax: 270-299-1059

Progressive Speech, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 75 Policeman Way, Greensburg, KY 42743 Phone: 270-789-9537    Fax: 270-932-9811

Erin Whitlock Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 116 Woodson Dr, Greensburg, KY 42743 Phone: 606-584-1169

News Archive

Study finds excessive screen time exposure among children

A study conducted by the University at Albany, the National Institutes of Health and New York University Langone Medical Center uncovered several new findings about the amount of time children spend watching television or using a computer or mobile device.

Tornier announces two milestone events for Simpliciti stemless shoulder system

Tornier N.V., a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced two milestone events for the Company's new SimplicitiTM stemless shoulder joint replacement system.

Intellect Neurosciences receives Notice of Allowance for new OXIGON patent in Canada

Intellect Neurosciences, Inc announced that it has received a Notice of Allowance from the Canadian Patent and Trademark Office for a new patent related to OX1 (OXIGON™), the Company's clinical-stage drug candidate that has disease-modifying potential for Alzheimer's and other neurodegenerative disorders. OX1 is an orally-administered, brain-penetrating, naturally-occurring, copper-binding small molecule targeting multiple mechanisms that contribute significantly to the underlying pathology of Alzheimer's disease.

Even with new medical schools opening, shortages mar workforce

Nearly two dozen medical schools have recently opened or may open across America, "the most at any time since the 1960s and '70s," The New York Times reports. These new institutions "are seeking to address an imbalance in American medicine that has been growing for a quarter century. Many bright students were fleeing to offshore medical schools, or giving up hope entirely, when they could not get into domestic schools. Meanwhile, American hospitals were using foreign-trained and foreign-born physicians to fill medical residencies. During the 1980s and '90s only one new medical school was established."

Read more Medical News

› Verified 1 days ago